Sartorius Stedim Biotech S.A.

Paris Stock Exchange DIM.PA

Sartorius Stedim Biotech S.A. Inventory for the year ending December 31, 2023: USD 973.95 M

Sartorius Stedim Biotech S.A. Inventory is USD 973.95 M for the year ending December 31, 2023, a -11.17% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.
  • Sartorius Stedim Biotech S.A. Inventory for the year ending December 31, 2022 was USD 1.10 B, a 23.02% change year over year.
  • Sartorius Stedim Biotech S.A. Inventory for the year ending December 31, 2021 was USD 891.28 M, a 54.48% change year over year.
  • Sartorius Stedim Biotech S.A. Inventory for the year ending December 31, 2020 was USD 576.95 M, a 56.66% change year over year.
  • Sartorius Stedim Biotech S.A. Inventory for the year ending December 31, 2019 was USD 368.28 M, a 27.69% change year over year.
Key data
Date Inventory Goodwill Total Assets Current Liabilities
Market news
Loading...
SV Wall Street
Paris Stock Exchange: DIM.PA

Sartorius Stedim Biotech S.A.

CEO Dr. Rene Faber
IPO Date Jan. 3, 2000
Location France
Headquarters Zone Industrielle Les Paluds
Employees 10,082
Sector Healthcare
Industries
Description

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Similar companies

DSY.PA

Dassault Systèmes SE

USD 42.69

1.14%

BIM.PA

bioMérieux S.A.

USD 121.52

0.77%

ERF.PA

Eurofins Scientific SE

USD 53.54

0.02%

WLN.PA

Worldline SA

USD 8.22

-0.13%

TEP.PA

Teleperformance SE

USD 94.63

-0.08%

StockViz Staff

February 7, 2025

Any question? Send us an email